Vanderbilt University Medical Center: Study Evaluates Polygenic Risk Score for Prostate Cancer Risk Prediction
March 18, 2023
March 18, 2023
NASHVILLE, Tennessee, March 18 (TNSjou) -- Vanderbilt University Medical Center issued the following news:
By Leigh MacMillan
A prostate cancer polygenic risk score (PRS) has limited utility for enhancing prostate cancer screening, according to a new study published in JAMA Internal Medicine.
Vanderbilt University Medical Center researchers led the study to evaluate whether a prostate cancer PRS, an indicator of an individual's "burden" of prostat . . .
By Leigh MacMillan
A prostate cancer polygenic risk score (PRS) has limited utility for enhancing prostate cancer screening, according to a new study published in JAMA Internal Medicine.
Vanderbilt University Medical Center researchers led the study to evaluate whether a prostate cancer PRS, an indicator of an individual's "burden" of prostat . . .